Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
This report contains market size and forecasts of Opioid Receptor Agonist in global, including the following market information:
Global Opioid Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Receptor Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Opioid Receptor Agonist companies in 2021 (%)
The global Opioid Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fentanyl Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Receptor Agonist include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioid Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
Fentanyl
Codeine
Morphine
Others
Global Opioid Receptor Agonist Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioid Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Opioid Receptor Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioid Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Receptor Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Receptor Agonist revenues share in global market, 2021 (%)
Key companies Opioid Receptor Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Opioid Receptor Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior